Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,912,192
-$317,696 QoQ
Shares Held
79,410
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#990
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penobscot Investment Management Company, Inc. holds $78,402,280 across 11 Drug Manufacturers - General names. PFE ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,452 | $19,490,021 | |
| 2 | LLY |
ELI LILLY & Co
|
12,634 | $15,153,599 | |
| 3 | JNJ |
Johnson & Johnson
|
55,938 | $14,206,573 | |
| 4 | AZN |
Astrazeneca PLC
|
60,174 | $11,410,193 | |
| 5 | AMGN |
Amgen Inc
|
16,503 | $5,976,066 | |
| 6 | NVS |
Novartis AG
|
26,577 | $4,165,147 | |
| 7 | MRK |
Merck & Co., Inc.
|
31,382 | $4,032,587 | |
| 8 | PFE |
Pfizer Inc
This page
|
79,410 | $1,912,192 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,912,192 | 79,410 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,229,888 | 79,412 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,998,200 | 80,249 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $2,084,875 | 81,824 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,090,118 | 86,226 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,414,927 | 95,301 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,461,294 | 92,774 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,735,234 | 94,514 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,563,639 | 91,624 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,558,244 | 92,189 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,964,477 | 102,969 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,440,358 | 103,719 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,342,354 | 91,122 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,738,177 | 91,622 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,790,273 | 93,487 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,090,990 | 93,487 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $4,901,522 | 93,487 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,839,821 | 93,487 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $5,513,793 | 93,375 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,016,058 | 93,375 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,644,816 | 93,075 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $3,461,666 | 95,547 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $3,708,864 | 100,757 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,444,511 | 93,856 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,109,968 | 95,106 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $3,104,255 | 95,106 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||